StockVS

Archimedes Tech SPAC Partners III Co. (ARCIU) 주식 분석

금융 서비스

Archimedes Tech SPAC Partners III Co.

$10.08

+$0.03 (+0.30%)

최종 업데이트: 2026년 5월 26일

가격 추이

분석

회사 개요

Archimedes Tech SPAC Partners III Co. is a special purpose acquisition company dedicated to executing business combinations, which include mergers, amalgamations, share exchanges, asset acquisitions, share purchases, or reorganizations with one or more target businesses. This entity operates within the Financial Services sector, specifically under the industry classification of Shell Companies, a designation that reflects its status as a publicly traded vehicle waiting for a merger rather than an operating business with existing revenue streams. The company currently reports a market capitalization of N/A, has not disclosed specific annual revenue figures, and lists an employee count of N/A. These financial metrics indicate that the company is a pre-merger shell entity without established operational scale, meaning its valuation and revenue data are not yet derived from business operations but rather from market speculation regarding its potential future merger target.

재무 건전성

The company reports a trailing twelve-month net income of $-166,850, while both revenue and EBITDA figures are listed as N/A, suggesting that the financial statements reflect the costs of maintaining a shell structure rather than operational earnings. The gap between revenue and net income reveals a cost structure where the company incurs significant expenses, likely related to SPAC maintenance fees and administrative costs, without generating corresponding operating revenue. Free cash flow data is unavailable (N/A), which implies that the company lacks the operational cash generation typically seen in mature businesses and relies entirely on its trust account or capital markets for liquidity. All three margins—gross margin, operating margin, and profit margin—are reported at 0.0%, indicating that the company has not yet generated any gross profit or operating income to cover its costs. The company holds N/A in cash and carries N/A in debt, resulting in a debt-to-equity ratio of N/A, which prevents a definitive assessment of leverage but suggests a balance sheet currently structured around a SPAC trust rather than operational financing. The current ratio stands at 0.11, a figure that indicates severe short-term liquidity constraints, as the company's current assets are insufficient to cover its current liabilities without external funding. Return on Equity and Return on Assets are both listed as N/A, reflecting the fact that traditional return metrics cannot be calculated in the absence of significant equity or asset base derived from operations.

밸류에이션 평가

The trailing P/E ratio is N/A, and the forward P/E is also N/A, meaning that traditional earnings-based valuation multiples cannot be applied to determine if the stock is cheap or expensive based on current profitability. The price-to-book ratio is listed as -1111.11, a negative figure that indicates the market price is significantly below the book value per share, a common characteristic for SPACs with low trust account balances relative to their share count. The price-to-sales ratio and EV/EBITDA are both N/A, as these metrics require positive sales and earnings data that this shell company has not yet achieved. The stock has traded within a range defined by a 52-week high of $10.15 and a 52-week low of $9.99, placing the current valuation within a narrow band that reflects high volatility typical of untargeted SPACs. The beta value is N/A, which prevents a direct comparison of price volatility relative to the broader market index using standard statistical measures.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are both listed as N/A, as the company has not yet established a track record of growth from business operations. Since the company does not pay a dividend, with a dividend yield of N/A and a payout ratio of N/A, it follows the standard SPAC model of reinvesting any available capital into the search for a merger target rather than distributing income to shareholders. The overall growth and income profile is currently non-existent in terms of operational performance, with all growth metrics remaining undefined until a business combination is successfully completed. The absence of dividend payments and the lack of historical growth data underscore the speculative nature of the investment, where potential future returns depend entirely on the success of the upcoming merger rather than current financial performance.

동종업체 비교

Archimedes Tech SPAC Partners III Co. (ARCIU) 은(는) 페이퍼 컴퍼니 산업에서 운영됩니다. 시가총액 기준으로 가장 가까운 동종업체와의 비교는 다음과 같습니다:

기업명 티커 시가총액 PER
Archimedes Tech SPAC Partners III Co. ARCIU N/A N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

페이퍼 컴퍼니 산업 평균 PER은 82.8배입니다. Archimedes Tech SPAC Partners III Co.의 PER은 N/A입니다.

이 분석은 AI가 생성한 것으로 정보 제공 목적으로만 사용되며 투자 조언이 아닙니다. 데이터가 지연되거나 부정확할 수 있습니다. 투자 결정을 내리기 전에 항상 직접 조사하고 자격을 갖춘 재무 상담사와 상담하세요.

Archimedes Tech SPAC Partners III Co. 소개

Archimedes Tech SPAC Partners III Co. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Claymont, Delaware.

회사 설명은 영어로 표시됩니다.

웹사이트 방문 →

주요 지표

시가총액
N/A
PER
N/A
52주 최고가
$10.15
52주 최저가
$9.99
평균 거래량
14.51K

데이터는 yfinance를 통해 Yahoo Finance에서 제공됩니다. 매일 업데이트.

기업 정보

거래소
NASDAQ
국가
United States